𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progression of pulmonary cystic disease during ECMO

✍ Scribed by G. W. Gross; J. Cullen; H. J. Desai

Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
354 KB
Volume
20
Category
Article
ISSN
0301-0449

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Unexpected rapid progression of metastat
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate
✍ Ching-Hung Lin; Roh-Fan Yen; Yung-Ming Jeng; Chin-Yuan Tzen; Chiun Hsu; Ruey-Lon πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 182 KB

## Abstract ## Background. There is a lack of effective treatment for metastatic adenoid cystic carcinoma (ACC), a usually indolent tumor. We studied the efficacy of imatinib mesylate, a potent inhibitor of KIT tyrosine kinase, in patients with KIT‐positive metastatic ACC. ## Methods. Five patie

Evaluation of long term tobramycin thera
Evaluation of long term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease
✍ U. Paporisz; H. G. Posselt; R. WΓΆnne; W. Ristow; D. RΓΆser; H. Knothe; S. W. Bend πŸ“‚ Article πŸ“… 1979 πŸ› Springer 🌐 English βš– 493 KB

To nine cystic fibrosis patients with chronic bronchopulmonary infection of severely damaged lungs invaded by Pseudomonas aeruginosa, eleven courses of prolonged tobramycin treatment (5 mg/kg/day) for four to 16 weeks were administered. Pulmonary symptoms improved and a better quality of life was ac

Dynamic perfusion MRI: Capability for ev
Dynamic perfusion MRI: Capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease
✍ Yoshiharu Ohno; Hisanobu Koyama; Munenobu Nogami; Daisuke Takenaka; Sumiaki Mats πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 888 KB

## Abstract ## Purpose To prospectively evaluate the capability of dynamic perfusion MRI for assessment of disease severity and progression to pulmonary arterial hypertension (PAH) in connective tissue disease (CTD) patients. ## Materials and Methods In all, 18 gender‐ and age‐matched CTD patien